Form 8-K - Current report:
SEC Accession No. 0000950170-24-119791
Filing Date
2024-11-01
Accepted
2024-11-01 06:05:23
Documents
13
Period of Report
2024-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsx-20241101.htm   iXBRL 8-K 40446
2 EX-99.1 bdsx-ex99_1.htm EX-99.1 277246
3 GRAPHIC img189760734_0.jpg GRAPHIC 3310
  Complete submission text file 0000950170-24-119791.txt   462839

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bdsx-20241101.xsd EX-101.SCH 31904
15 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20241101_htm.xml XML 4698
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 241416831
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)